Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography.
about
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patientsStent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014Intravascular Ultrasound and Angiographic Predictors of In-Stent Restenosis of Chronic Total Occlusion LesionsAn effective approach to reduce inflammation and stenosis in carotid artery: polypyrrole nanoparticle-based photothermal therapy.Arterial stiffness in patients with coronary artery disease: relation with in-stent restenosis following percutaneous coronary intervention.Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease.Comparison of First- and Second-Generation Drug-Eluting Stents in an All-Comer Population of Patients with Diabetes Mellitus (from Katowice-Zabrze Registry).Association of the Endothelial Nitric Oxide Synthase Gene T786C Polymorphism with In-Stent Restenosis in Chinese Han Patients with Coronary Artery Disease Treated with Drug-Eluting Stent.Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials.Drug-coated balloons for the treatment of in-stent restenosis in diabetic patients: A review of currently available scientific data.Blood Pressure Levels at the Time of Percutaneous Coronary Revascularization and Risk of Coronary In-Stent RestenosisFive-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trialLow and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention.Effects of Low Endothelial Shear Stress After Stent Implantation on Subsequent Neointimal Hyperplasia and Clinical Outcomes in HumansIn-Hospital and One-Year Clinical Outcome of Percutaneous Coronary Intervention in a Tertiary Hospital in Oman: Oman PCI Registry.Comparison of floating wire and single wire techniques in right coronary ostial lesions in terms of procedural features and one-year clinical follow-up results.Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials.Coronary Bifurcation Intervention: What Role Do Bifurcation Angles Play?Bioresorbable vascular scaffold to treat in-stent restenosis: Single-center experience.Treatment of coronary artery in-stent restenosis.Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.Late clinical outcomes for SeQuent please paclitaxel-coated balloons in PCI of instent restenosis and de novo lesions: A single-center, real world registry.Comparison of the Absorbable Polymer Sirolimus-Eluting Stent (MiStent) to the Durable Polymer Everolimus-Eluting Stent (Xience) (from the DESSOLVE I/II and ISAR-TEST-4 Studies).Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: Results of the ISAR-ABSORB registry.Association of contrast-induced nephropathy with bare metal stent restenosis in STEMI patients treated with primary PCI.The Value of Multi-slice Computed Tomography Compared to Conventional Coronary Angiography for Detecting In-stent Restenosis.Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.Implantation of everolimus-eluting bioresorbable scaffolds in a diabetic all-comers population.Diagnosis and management challenges of in-stent restenosis in coronary arteries.Intravascular ultrasound guidance in drug-eluting stents implantation: a meta-analysis and trial sequential analysis of randomized controlled trialsTreatment of coronary in-stent restenosis-evidence for universal recommendation?Drug-eluting stent restenosis treatment: an "old" stent, a "new" balloon or a "newer" scaffold?Best percutaneous coronary intervention approach for small caliber coronary arteriesImpact of stent length and diameter on short term clinical outcomes of drug eluting stents in patients with stable coronary artery diseasePrognostic Value of Plasma Long Noncoding RNA ANRIL for In-Stent Restenosis.Mechanism of in-stent restenosis after second-generation drug-eluting stents (DES): is it different from bare-metal stents and first-generation DES?In-stent neoatherosclerosis and tissue characteristics of restenotic lesions following implantation of second generation drug-eluting stents in unrestricted coronary lesions: Optical frequency domain imaging study.Inhibition of neddylation by MLN4924 improves neointimal hyperplasia and promotes apoptosis of vascular smooth muscle cells through p53 and p62.Incidence, procedural management, and clinical outcomes of coronary in-stent restenosis: Insights from the National VA CART Program.Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.
P2860
Q26780172-F2C6A8D1-7F56-48AC-ACE0-BE514C5540DAQ26785321-E11B531E-92C3-4312-9E90-CB93D1A5FFE8Q28550254-CCED1FE1-1A7E-46A6-872E-8B7993B77331Q35592616-1D803BBA-31A0-4D81-8D80-05C12035900DQ36041966-FCE2BEB8-63AF-41E7-8E3E-F6818D4FBA94Q36204864-450C5134-9730-49F1-84FB-C1C52A5C4F3FQ36239147-04C1E9CE-AA5A-4DA6-BBF7-66B307CE74DCQ36262657-322D4B79-78AF-42D8-961F-D26688E9DAF4Q36353650-B32F242C-5788-4EBF-B735-818710960548Q36381320-56EB88E3-53FB-480B-8F5A-E6BBE4F8B1C0Q36950156-FB03903B-7B6B-4A15-8EA4-E10670C1257BQ37228675-9BE9450D-492B-45CF-ABE8-363A7B142788Q37326200-BCF60CB1-C5FF-4A45-9491-3BE609FDAE20Q37364362-A7840568-9005-4089-8E8B-531465B362CCQ37533177-F879C052-BB5C-4D89-8FE9-975E96FDD444Q37680584-3AACB4B4-3B60-4C37-9D93-00E2D970DE7AQ38398230-A50A8628-E225-43BF-9B3A-1DAF7E00AF6BQ38525049-FD9F372D-D492-4FD6-928C-85A3D811989CQ38635400-50CA6386-9177-453B-A1EC-5EEB0B983E52Q38766516-00CCFBA8-B09E-4DFC-A23E-87647B3435CBQ38819089-87FDE0D4-2C34-44D1-8FCC-9B8092170DCCQ39822716-4BC2ADB9-0240-409B-BDCE-D62E155894E0Q40112459-E4C75926-6EFF-46D4-8478-4A56182278DBQ40167885-136E573C-F3C6-4A38-B7B9-2982C1C38B11Q40642312-67DFF8F2-7D71-4FEF-A509-D8169C9BBDCBQ41321160-C4F880E7-8407-45F9-B3E5-416669C2FACFQ41420992-C8BAE66B-01F8-4D88-AF07-2301A5D71E5CQ41486976-5719BED6-9EF2-4F4D-9A24-235AAB5C7EDAQ41608247-5E075CA7-E756-4297-B72D-2499832292CAQ41708784-C0896FEB-14FE-4C58-B158-7B03DF3C5381Q42064609-F4C1E1A1-D36F-43F6-AC64-0CC38C4DA97EQ42331426-A78D00E8-D052-4E75-B9B8-43D1AA40B72BQ42369264-5E30C350-999D-4418-9A92-5146CA5F28C6Q42669540-13CBDB0A-F255-4FB3-84F2-4B8AA111A7D8Q42705467-34A44405-91A2-4D31-8C43-1362E7AF49B7Q43102467-1D6C6E7F-BA01-48D3-BED3-C17E1A79546EQ46457233-E754B664-2060-4E8D-BDF8-E99C87319BD4Q47804035-925D8ADE-AA89-43FC-BB9E-27E3F486E60BQ47843135-45412296-E492-42DE-B596-37701C79B2BBQ48199206-8E7143AA-C84D-4CA7-AFDB-5ECACFB7ED5C
P2860
Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Incidence and predictors of re ...... with surveillance angiography.
@en
Incidence and predictors of re ...... with surveillance angiography.
@nl
type
label
Incidence and predictors of re ...... with surveillance angiography.
@en
Incidence and predictors of re ...... with surveillance angiography.
@nl
prefLabel
Incidence and predictors of re ...... with surveillance angiography.
@en
Incidence and predictors of re ...... with surveillance angiography.
@nl
P2093
P1433
P1476
Incidence and predictors of re ...... with surveillance angiography.
@en
P2093
Lamin A King
Massimiliano Fusaro
Michael Joner
Robert A Byrne
Salvatore Cassese
Susanne Pinieck
Tareq Ibrahim
Tomohisa Tada
P304
P356
10.1136/HEARTJNL-2013-304933
P407
P577
2013-11-22T00:00:00Z